Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hepatology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.23123PMID 19711424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of

  2020cited by this paper
• Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

  2009cited by this paper
• Exceeding the limits of liver histology markers.

  2009cited by this paper
• New technologies for human cancer imaging.

  2008cited by this paper
• Microscale culture of human liver cells for drug development

  2008cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.

  2008cited by this paper
• Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

  2008cited by this paper
• Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography

  2008cited by this paper
• Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

  2008cited by this paper
• Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients.

  2008cited by this paper
• Diagnosis and quantitation of fibrosis.

  2008cited by this paper
• Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

  2008cited by this paper
• Interstrain differences in susceptibility to non‐alcoholic steatohepatitis

  2008cited by this paper
• An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

  2008cited by this paper
• PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells.

  2008cited by this paper
• Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C

  2008cited by this paper
• MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging

  2008cited by this paper
• Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression

  2008cited by this paper
• Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.

  2008cited by this paper
• Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia

  2008cited by this paper
• The hedgehog pathway regulates remodelling responses to biliary obstruction in rats

  2008cited by this paper
• Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.

  2008cited by this paper
• Cellular Targeting of the Apoptosis-Inducing Compound Gliotoxin to Fibrotic Rat Livers

  2008cited by this paper
• Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

  2008cited by this paper
• Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone

  2008cited by this paper
• Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.

  2008cited by this paper
• Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

  2008cited by this paper
• Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.

  2008cited by this paper
• Non-invasive evaluation of liver fibrosis using transient elastography.

  2008cited by this paper
• PROTECTION BY AND ANTI‐OXIDANT MECHANISM OF BERBERINE AGAINST RAT LIVER FIBROSIS INDUCED BY MULTIPLE HEPATOTOXIC FACTORS

  2008cited by this paper
• Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats

  2008cited by this paper
• Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

  2008cited by this paper
• Liver cirrhosis.

  2008cited by this paper
• Role of αvβ6 integrin in acute biliary fibrosis

  2007cited by this paper
• Computer-aided diagnosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network.

  2007cited by this paper
• Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis.

  2007cited by this paper
• Prevention of liver cirrhosis in rats by curcumin

  2007cited by this paper
• Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats

  2007cited by this paper
• CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis

  2007cited by this paper
• Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non‐transplanted patients with chronic hepatitis C

  2007cited by this paper
• The role of electrophoresis in disease biomarker discovery

  2007cited by this paper
• Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.

  2007cited by this paper
• Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.

  2007cited by this paper
• Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro*

  2007cited by this paper
• Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice

  2007cited by this paper
• Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

  2007cited by this paper
• A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.

  2007cited by this paper
• Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

  2007cited by this paper
• Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices.

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007influential reference
• Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

  2007cited by this paper
• Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications

  2007cited by this paper
• Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

  2007cited by this paper
• Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation

  2007cited by this paper
• Microscale control of cell contact and spacing via three-component surface patterning.

  2007cited by this paper
• Complementary and alternative medicine in hepatology: review of the evidence of efficacy.

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Role of alphavbeta6 integrin in acute biliary fibrosis.

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

  2006cited by this paper
• Inhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice

  2006cited by this paper
• Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis

  2006cited by this paper
• Longitudinal evaluation of a fibrosis index combining MMP‐1 and PIIINP compared with MMP‐9, TIMP‐1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon‐alpha and ribavirin

  2006cited by this paper
• Reversal of hepatic fibrosis — Fact or fantasy?

  2006cited by this paper
• Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

  2006cited by this paper
• The bone marrow functionally contributes to liver fibrosis.

  2006cited by this paper
• Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NFκB*

  2006cited by this paper
• Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

  2006cited by this paper
• Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.

  2006cited by this paper
• CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

  2006cited by this paper
• Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.

  2006cited by this paper
• Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.

  2006cited by this paper
• Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

  2005cited by this paper
• Attenuated liver fibrosis in the absence of B cells.

  2005cited by this paper
• Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu.

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Herbal hepatotoxicity.

  2005cited by this paper
• Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.

  2005cited by this paper
• Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis

  2005cited by this paper
• Antifibrotic therapy in chronic liver disease.

  2005cited by this paper
• Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

  2005cited by this paper
• Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282)

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

  2005cited by this paper
• Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.

  2005cited by this paper
• The impact of pharmacophore modeling in drug design.

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection

  2005cited by this paper
• Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C.

  2005cited by this paper
• Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

  2004cited by this paper
• The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse

  2004cited by this paper
• The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.

  2004cited by this paper
• Liver fibrosis

  2004cited by this paper
• Drug repositioning: identifying and developing new uses for existing drugs

  2004cited by this paper
• A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.

  2004cited by this paper
• Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

  2004cited by this paper
• Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth.

  2004cited by this paper
• Development of TGF-β signalling inhibitors for cancer therapy

  2004cited by this paper

• Sofosbuvir’s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes

  2025cites this paper
• A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms

  2025influential citation
• Nanomedicines in the Treatment of Liver Fibrosis: A Review

  2025cites this paper
• ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer

  2024cites this paper
• Reducing Nogo-B Improves Hepatic Fibrosis by Inhibiting BACe1-Mediated Autophagy

  2024cites this paper
• Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis.

  2024cites this paper
• A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis

  2024cites this paper
• Erratum to Oxymatrine attenuates arsenic-induced endoplasmic reticulum stress and calcium dyshomeostasis in hepatic stellate cells

  2024cites this paper
• The protective effect of the vagus nerve-α7nAChR-IL-22 pathway on acute liver injury.

  2024cites this paper
• The role of long noncoding RNA MEG3 in fibrosis diseases.

  2024cites this paper
• Single-cell RNA seq identifies Plg-RKT-PLG as signals inducing phenotypic transformation of scar-associated macrophage in liver fibrosis.

  2023cites this paper
• Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis

  2023cites this paper
• Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti‐Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis

  2023cites this paper
• Models of Hepatotoxicity for the Study of Chronic Liver Disease

  2023cites this paper
• Integrative Transcriptomic Analysis Reveals Upregulated Apoptotic Signaling in Wound-Healing Pathway in Rat Liver Fibrosis Models

  2023cites this paper
• RNA nanomedicine in liver diseases

  2023cites this paper
• Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative Diseases.

  2023cites this paper
• MFAP2 promotes HSCs activation through FBN1/TGF‐β/Smad3 pathway

  2023cites this paper
• Corylin Attenuates CCl4-Induced Liver Fibrosis in Mice by Regulating the GAS6/AXL Signaling Pathway in Hepatic Stellate Cells

  2023cites this paper
• Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseases

  2023cites this paper
• Conformationally Restricted Dipeptide-Based Nanoparticles for Delivery of siRNA in Experimental Liver Cirrhosis

  2022cites this paper
• Niacin regresses collagen content in human hepatic stellate cells from liver transplant donors with fibrotic non-alcoholic steatohepatitis (NASH).

  2022cites this paper
• Pathophysiology of metalloproteinase matrix in relation to morbid obesity and associated pathologies

  2022cites this paper
• Modelling fatty liver disease with mouse liver-derived multicellular spheroids.

  2022cites this paper
• Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway

  2022cites this paper
• Rosa26-LSL-dCas9-VPR: a versatile mouse model for tissue specific and simultaneous activation of multiple genes for drug discovery

  2022cites this paper
• Myofibroblast specific targeting approaches to improve fibrosis treatment.

  2022cites this paper
• TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway.

  2022cites this paper
• Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?

  2022cites this paper
• Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

  2022cites this paper
• Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis

  2022cites this paper
• The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling.

  2022cites this paper
• Cellular Protein Markers, Therapeutics, and Drug Delivery Strategies in the Treatment of Diabetes-Associated Liver Fibrosis.

  2021cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• Обзор исследований прогрессии фиброза печёночной ткани после трансплантации печени

  2021cites this paper
• Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model

  2021cites this paper
• DDDT_A_281369 871..887

  2021cites this paper
• Taxifolin, Extracted from Waste Larix olgensis Roots, Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/mTOR and TGF-β1/Smads Signaling Pathways

  2021cites this paper
• Biochemical and molecular study on the beneficial effect of Solubilized coenzyme Q10 on thioacetamide-induced liver fibrosis in adult male rats

  2021cites this paper
• Evaluation of the Possible Protective Role of Ginger on Sodium Valproate Induced Hepatotoxicity in Adult Male Albino Rat: A Biochemical, Histological, And Immunohistochemical Study

  2021cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis

  2021cites this paper
• Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism.

  2021cites this paper
• Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease

  2020cites this paper
• Predictors of NAFLD rapidly progression in type 2 diabetes patients

  2020cites this paper
• Molecular imaging of extracellular matrix proteins with targeted probes using magnetic resonance imaging.

  2020cites this paper
• Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis

  2020influential citation
• Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model

  2020cites this paper
• Karaciğer Fibrozis Modellerinde Sık Kullanılan Kimyasal Ajanların Farklı Doz ve Zaman Dilimindeki Etkilerinin Belirlenmesi

  2020cites this paper
• Experimental model for the evaluation of metabolic status after gastric bypass in obese rats

  2020cites this paper
• Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC).

  2020cites this paper
• Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

  2020cites this paper
• Oxymatrine attenuates arsenic-induced endoplasmic reticulum stress and calcium dyshomeostasis in hepatic stellate cells

  2020cites this paper
• Role of acoustic radiation force impulse elastography, aminotransferase to platelet ratio index and fibrotest for the assessment of significant fibrosis and cirrhosis in chronic liver disease

  2020cites this paper
• A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage

  2020cites this paper
• Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways.

  2020cites this paper
• Oxymatrine exerts anti-fibrotic effects in a rat model of hepatic fibrosis by suppressing endoplasmic reticulum stress

  2020cites this paper
• Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases.

  2020cites this paper
• Hepatic Bile Formation: Bile acid transport and water flow in the canalicular conduit.

  2020cites this paper
• Short hairpin RNA attenuates liver fibrosis by regulating the PPAR-γ and NF-κB pathways in HBV-induced liver fibrosis in mice

  2020cites this paper
• Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence.

  2020cites this paper
• Collagen-targeted molecular imaging in diffuse liver diseases

  2020cites this paper
• Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats

  2020cites this paper
• A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction

  2020cites this paper
• Role of cell autophagy in the generation of IgM and hepatic fibrosis in primary biliary cholangitis

  2020cites this paper
• Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages

  2020cites this paper
• ASK1 Enhances Angiotensin II-Induced Liver Fibrosis In Vitro by Mediating Endoplasmic Reticulum Stress-Dependent Exosomes

  2020cites this paper
• Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis

  2020cites this paper
• MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.

  2019cites this paper
• Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling

  2019cites this paper
• Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways.

  2019cites this paper
• Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.

  2019cites this paper
• MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription

  2019cites this paper
• Antifibrotic Therapy for Liver Cirrhosis

  2019cites this paper
• Current Advances in the Synthesis and Biological Evaluation of Pharmacologically Relevant 1,2,4,5-Tetrasubstituted-1H-Imidazole Derivatives

  2019cites this paper
• The Evolving Landscape of Liver Cirrhosis Management

  2019cites this paper
• MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2

  2019cites this paper
• Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis

  2019cites this paper
• Efficiency of Sophora flavescens-Fructus Ligustri Lucidi Drug Pairs in the Treatment of Liver Fibrosis Based on the Response Surface Method

  2019cites this paper
• Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation

  2019cites this paper
• Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis

  2019cites this paper
• miRNA‐200b improves hepatic fibrosis induced by CCL4 by regulating toll‐like receptor 4 in mice

  2019cites this paper
• Carvedilol attenuates carbon tetrachloride-induced liver fi brosis and hepatic sinusoidal capillarization in mice

  2019cites this paper
• Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice

  2019cites this paper
• Short hairpin RNA attenuates liver fibrosis by regulating the peroxisome proliferator-activated receptor-γ and nuclear factor-κB pathways in hepatitis B virus-induced liver fibrosis in mice

  2019cites this paper
• asiatic acid ameliorates ccl 4 -induced liver fibrosis in rats: involvement of Nrf2/ARE, NF- κ B/ i κ B α , and JAK1/STAT3 signaling pathways

  2018cites this paper
• MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition

  2018cites this paper
• Oleanolic Acid-amino Acids Derivatives: Design, Synthesis, and Hepatoprotective Evaluation In Vitro and In Vivo

  2018cites this paper
• Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.

  2018cites this paper
• Multifaceted esculetin suppresses hepatic stellate cell activation and CCl4-induced liver fibrosis in mice

  2018cites this paper
• Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific Microenvironment

  2018cites this paper
• Pharmacokinetics of a sustained release formulation

  2018cites this paper
• cM-101: Type I Collagen–targeted MR Imaging Probe for Detection of Liver Fibrosis 1

  2018cites this paper
• Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats

  2018cites this paper
• Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

  2018cites this paper
• linc‐SCRG1 accelerates liver fibrosis by decreasing RNA‐binding protein tristetraprolin

  2018cites this paper
• Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer 99mTc-GlcNAc-PEI for liver fibrosis imaging with SPECT

  2018cites this paper
• Asiatic acid ameliorates CCl4-induced liver fibrosis in rats: involvement of Nrf2/ARE, NF-κB/IκBα, and JAK1/STAT3 signaling pathways

  2018cites this paper
• Determinants of fibrosis progression and regression in NASH.

  2018influential citation
• S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3/SMAD3 pathway.

  2018cites this paper